Exports In 2022, Malaysia exported $11.7M in Vaccines, blood, antisera, toxins and cultures, making it the 70th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 609th most exported product in Malaysia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Malaysia are: Australia ($3.6M), Burma ($2.48M), Brunei ($1.51M), Singapore ($1.25M), and Switzerland ($816k).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Malaysia between 2021 and 2022 were Australia ($2.64M), Burma ($2.25M), and Switzerland ($814k).
Imports In 2022, Malaysia imported $528M in Vaccines, blood, antisera, toxins and cultures, becoming the 55th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 99th most imported product in Malaysia. Malaysia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($132M), Switzerland ($85.5M), Belgium ($60.7M), United States ($49.3M), and France ($42.6M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Malaysia between 2021 and 2022 were United Arab Emirates ($29M), Germany ($28.7M), and Thailand ($5.43M).
COMPANIES In 2023, leading companies such as Tesla (2) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Malaysia to the United States.